Cathie Wood’s 5 Latest Stock Picks Under $10

2. Surface Oncology, Inc. (NASDAQ:SURF)

Number of Hedge Fund Holders: 10  

Share Price as of November 18: $6.10

According to regulatory filings, ARK Investment Management owned 4.4 million shares in Surface Oncology, Inc. (NASDAQ:SURF) at the end of September 2021 worth $33 million, representing 0.06% of the portfolio. The fund increased stake in the company by 11% compared to the filings for the end of June.  

Surface Oncology, Inc. (NASDAQ:SURF) is a clinical stage biotech firm. BTIG analyst Justin Zelin has a Buy rating on the stock with a price target of $17. 

At the end of the second quarter of 2021, 10 hedge funds in the database of Insider Monkey held stakes worth $58 million in Surface Oncology, Inc. (NASDAQ:SURF), down from 15 in the preceding quarter worth $54 million.